Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination. [electronic resource]
Publication details: Neurology. Clinical practice Dec 2017Description: 534-537 p. digitalISSN:- 2163-0402
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.